Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.
Dianthus Therapeutics is offering Nanjing Leads Biolabs up to $1 billion biobucks for licensing rights to a bispecific antibody designed to treat certain autoimmune disorders. | Dianthus Therapeutics ...
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell ...
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...
Ariana Villalobos-Castillo was just one month away from her Oxnard High School graduation when she learned she wasn’t going ...
MotorTrend on MSN
Smile, You’re on an In-Car Camera!
Interior cameras began by combating driver distraction and drowsiness and now can capture everything from occupant health to ...
Breakups are never easy, but for some people, they’re downright chaotic. Emotions run high, logic goes out the window, and ...
As electric bicycles surge in popularity, crashes and fatalities spark calls for better safety, regulation and infrastructure ...
Well-meaning parents can hurt when they try to help too much. New research shows parent anxiety may drive overparenting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback